Specificity (SPTY) warns on 2025 results, delays Q1 10-Q amid errors
Rhea-AI Filing Summary
Specificity, Inc. reported that investors should no longer rely on its previously issued financial statements for the year ended December 31, 2025, after identifying accounting errors tied to bank and credit card accounts opened in mid-December 2025.
The company’s preliminary review indicates an approximate understatement of expenses of $83,422, understatement of revenues of $2,500, understatement of liabilities of $121,122, overstatement of additional paid-in capital of $40,000, and understatement of cash of $202. Specificity is preparing an amended Form 10-K/A for 2025 and completing its Form 10-Q for the quarter ended March 31, 2026, which it plans to file as soon as practical following review by its independent registered public accounting firm.
Positive
- None.
Negative
- Non-reliance on 2025 financial statements – The company determined that previously issued financial statements for the year ended December 31, 2025 should not be relied upon due to identified errors and will require a Form 10-K/A restatement.
- Delayed Q1 2026 filing – Completion of the Form 10-Q for the quarter ended March 31, 2026 has been delayed, with a Form 12b-25 filed to notify shareholders and the SEC of the late filing.
Insights
Specificity flags 2025 errors and plans a 10-K restatement.
Specificity, Inc. identified errors in its 2025 annual report, prompting a formal non‑reliance notice. The company attributes the issue to an inadvertent failure to obtain and review bank and credit card statements for accounts opened in mid‑December 2025.
The preliminary corrections involve an understatement of expenses of $83,422, revenues of $2,500, liabilities of $121,122, an overstatement of additional paid‑in capital of $40,000, and an understatement of cash of $202. These adjustments will be reflected in an amended Form 10‑K/A for the year ended December 31, 2025.
The company has also delayed its Form 10‑Q for the quarter ended March 31, 2026 and filed a Form 12b‑25 to notify of the late filing. The board and senior management have discussed the matter with independent auditor CM3 Advisory, and the restatement amounts remain subject to completion of CM3 Advisory’s review.
